Hunan Hansen Pharmaceutical Management
Management criteria checks 3/4
Hunan Hansen Pharmaceutical's CEO is Zhengqing Liu, appointed in Jan 2008, has a tenure of 17.33 years. directly owns 1.42% of the company’s shares, worth CN¥40.91M. The average tenure of the management team and the board of directors is 4.9 years and 5 years respectively.
Key information
Zhengqing Liu
Chief executive officer
CN¥1.7m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 17.3yrs |
| CEO ownership | 1.4% |
| Management average tenure | 4.9yrs |
| Board average tenure | 5yrs |
Recent management updates
CEO
Zhengqing Liu (60 yo)
Mr. Zhengqing Liu has been Chief Executive Officer and Non-Independent Director of Hunan Hansen Pharmaceutical Co., Ltd. since January 20, 2008 and serves as its Chairman since May 25, 2020.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 17.3yrs | CN¥1.68m | 1.42% CN¥ 40.9m | |
| VP, CFO & Board Secretary | 5yrs | CN¥284.60k | no data | |
| VP & MD of Hansen Research | 4.4yrs | CN¥324.60k | no data | |
| Director & VP | 4.9yrs | CN¥888.20k | no data | |
| Director & VP | 4.9yrs | CN¥328.20k | no data | |
| Vice President | 14.2yrs | CN¥311.70k | no data | |
| Accounting Supervisor | no data | no data | no data | |
| Vice President | 1.9yrs | no data | no data |
Experienced Management: 002412's management team is considered experienced (4.9 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman & CEO | 17.3yrs | CN¥1.68m | 1.42% CN¥ 40.9m | |
| Director & VP | 4.9yrs | CN¥888.20k | no data | |
| Director & VP | 4.9yrs | CN¥328.20k | no data | |
| Supervisor | 14.2yrs | no data | no data | |
| Independent Director | 5yrs | CN¥70.00k | no data | |
| Independent Director | 5yrs | CN¥70.00k | no data | |
| Independent Director | 5yrs | CN¥70.00k | no data | |
| Non-Independent Director | 2yrs | no data | no data | |
| Shareholder Supervisor | 2yrs | no data | no data |
Experienced Board: 002412's board of directors are considered experienced (5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/22 01:32 |
| End of Day Share Price | 2025/05/22 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hunan Hansen Pharmaceutical Co., Ltd. is covered by 12 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Yalei Yan | Bohai Securities Co., Ltd. |
| Songtao YE | Changjiang Securities Co. LTD. |
| Pei Hui Tang | Chasing Securities |